SCHEMBL2183604

SCHEMBL2183604

Cc1cccc(C(=O)Nc2cccc(NC(=O)COc3ccccc3Cl)c2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 9/20 0.64
KCNK9 Q9NPC2 8/20 0.64
KMT2A Q03164 8/20 0.61
MEN1 O00255 7/20 0.61
POLB P06746 2/20 0.61
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
TDP1 Q9NUW8 1/20 0.61
KCNH2 Q12809 1/20 0.60
SMN1; SMN2 Q16637 2/20 0.57
ALDH1A1 P00352 2/20 0.57
MAPT P10636 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
MITF O75030 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
PAX8 Q06710 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7239786 0.85 MEN1 (0.65) KMT2AMEN1POLBNPC1RAB9A
SCHEMBL17354700 0.79 MEN1 (0.68) KCNK3KCNK9KMT2AMEN1POLB
SCHEMBL15177176 0.78 KCNK3 (1.00) KCNK3KCNK9KMT2AMEN1POLB
SCHEMBL18327156 0.78 MAPT (0.79) KMT2AMEN1POLBNPC1RAB9A
SCHEMBL20898931 0.78 KMT2A (0.61) KMT2AMEN1POLBNPC1RAB9A
SCHEMBL7240676 0.77 MAPT (0.59) KMT2AMEN1POLBNPC1RAB9A
SCHEMBL23587927 0.75 MAPT (0.62) KMT2AMEN1POLBNPC1RAB9A
SCHEMBL4258402 0.75 KCNK3 (0.64) KCNK3KCNK9KMT2AMEN1POLB
SCHEMBL4253897 0.75 KCNK3 (0.93) KCNK3KCNK9KMT2AMEN1POLB
SCHEMBL7238805 0.74 RAB9A (0.78) KMT2AMEN1POLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9949980-B2 Drugs to prevent HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-04-24 US disclosed
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-22 US disclosed
US-9066951-B2 Drugs to treat HPV infection WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-06-30 US disclosed
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION WISCONSIN ALUMNI RESEARCH FOUNDATION 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165220-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A KCNK3 4184/4885KCNK9 4523/4885KMT2A 400/4885
US-20150297602-A1 DRUGS TO PREVENT HPV INFECTION VHL, PHF13, CDKN1A KCNK3 4184/4885KCNK9 4523/4885KMT2A 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.